Texas 2021 - 87th Regular

Texas House Bill HB1233 Latest Draft

Bill / Introduced Version Filed 01/21/2021

                            87R6646 MCF-D
 By: Crockett H.B. No. 1233


 A BILL TO BE ENTITLED
 AN ACT
 relating to prescribing low-THC cannabis under the Texas
 Compassionate Use Program.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Section 169.002, Occupations Code, is amended to
 read as follows:
 Sec. 169.002.  PHYSICIAN QUALIFIED TO PRESCRIBE LOW-THC
 CANNABIS [TO PATIENTS WITH CERTAIN MEDICAL CONDITIONS]. (a)  Only a
 physician qualified [with respect to a patient's particular medical
 condition] as provided by this section may prescribe low-THC
 cannabis in accordance with this chapter [to treat the applicable
 medical condition].
 (b)  A physician is qualified to prescribe low-THC cannabis
 to alleviate the symptoms of [with respect to] a patient's
 particular medical condition or the symptoms caused by other
 treatments for that medical condition if the physician:
 (1)  is licensed under this subtitle;
 (2)  is board certified in a medical specialty relevant
 to the treatment of the patient's particular medical condition by a
 specialty board approved by the American Board of Medical
 Specialties or the Bureau of Osteopathic Specialists; and
 (3)  dedicates a significant portion of clinical
 practice to the evaluation and treatment of the patient's
 particular medical condition, and the treatment of symptoms caused
 by that medical condition and by other treatments for that medical
 condition.
 SECTION 2.  Section 169.003, Occupations Code, is amended to
 read as follows:
 Sec. 169.003.  PRESCRIPTION OF LOW-THC CANNABIS. A
 physician described by Section 169.002 may prescribe low-THC
 cannabis to a patient if:
 (1)  the patient is a permanent resident of the state;
 (2)  the physician complies with the registration
 requirements of Section 169.004; and
 (3)  the physician certifies to the department that:
 (A)  the patient is diagnosed with a medical
 condition that produces symptoms, or the treatment of which
 produces symptoms, that are alleviated by medical use of low-THC
 cannabis [:
 [(i)  epilepsy;
 [(ii) a seizure disorder;
 [(iii) multiple sclerosis;
 [(iv) spasticity;
 [(v)  amyotrophic lateral sclerosis;
 [(vi) autism;
 [(vii) terminal cancer; or
 [(viii) an incurable neurodegenerative
 disease]; and
 (B)  the physician determines the risk of the
 medical use of low-THC cannabis by the patient is reasonable in
 light of the potential benefit for the patient.
 SECTION 3.  Sections 169.001(1-a) and (6), Occupations Code,
 are repealed.
 SECTION 4.  This Act takes effect September 1, 2021.